Sarana Meditama Metropolitan Cash Flow Conversion Efficiency
Sarana Meditama Metropolitan cash flow conversion efficiency. Based on the latest financial reports, Sarana Meditama Metropolitan (SAME) has a cash flow conversion efficiency ratio of 0.011x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rp44.49 Billion ≈ $2.61 Million USD) by net assets (Rp4.20 Trillion ≈ $246.10 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Sarana Meditama Metropolitan (2011–2025)
Cash flow conversion efficiency of Sarana Meditama Metropolitan from 2011 to 2025. This chart illustrates how Sarana Meditama Metropolitan's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Sarana Meditama Metropolitan (SAME) stock price for real-time trading data and today's change.
Sarana Meditama Metropolitan Cash Flow Conversion Ratio Explained
Sarana Meditama Metropolitan cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Sarana Meditama Metropolitan Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Sarana Meditama Metropolitan ranked by their cash flow conversion efficiency. Also see SAME market cap overview for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
AstroNova Inc
NASDAQ:ALOT
|
0.039x |
|
RF Capital Group Inc
TO:RCG
|
0.017x |
|
Egis Technology
TWO:6462
|
0.002x |
|
Pss Co Ltd
TW:6914
|
0.236x |
|
Nam Kim Steel JSC
VN:NKG
|
0.062x |
|
Dateline Resources Ltd
AU:DTR
|
-0.116x |
|
Copper Fox Metals Inc.
V:CUU
|
0.003x |
|
Bioteque
TWO:4107
|
0.036x |
Annual Cash Flow Conversion Efficiency for Sarana Meditama Metropolitan (2011–2025)
The table below shows the annual cash flow conversion efficiency of Sarana Meditama Metropolitan from 2011 to 2025. Review how much free cash does Sarana Meditama Metropolitan generate to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | Rp4.17 Trillion ≈ $244.10 Million |
Rp357.02 Billion ≈ $20.92 Million |
0.086x | +34.64% |
| 2024-12-31 | Rp4.14 Trillion ≈ $242.49 Million |
Rp263.42 Billion ≈ $15.44 Million |
0.064x | +67.33% |
| 2023-12-31 | Rp3.98 Trillion ≈ $233.42 Million |
Rp151.55 Billion ≈ $8.88 Million |
0.038x | +1481.24% |
| 2022-12-31 | Rp3.98 Trillion ≈ $233.39 Million |
Rp9.58 Billion ≈ $561.51K |
0.002x | -95.80% |
| 2021-12-31 | Rp4.43 Trillion ≈ $259.67 Million |
Rp253.74 Billion ≈ $14.87 Million |
0.057x | +244.24% |
| 2020-12-31 | Rp545.82 Billion ≈ $31.98 Million |
Rp-21.67 Billion ≈ $-1.27 Million |
-0.040x | -120.60% |
| 2019-12-31 | Rp977.50 Billion ≈ $57.28 Million |
Rp188.40 Billion ≈ $11.04 Million |
0.193x | +716.24% |
| 2018-12-31 | Rp1.33 Trillion ≈ $77.70 Million |
Rp31.31 Billion ≈ $1.83 Million |
0.024x | -62.85% |
| 2017-12-31 | Rp1.04 Trillion ≈ $61.07 Million |
Rp66.26 Billion ≈ $3.88 Million |
0.064x | -56.32% |
| 2016-12-31 | Rp850.97 Billion ≈ $49.86 Million |
Rp123.85 Billion ≈ $7.26 Million |
0.146x | +10.60% |
| 2015-12-31 | Rp741.18 Billion ≈ $43.43 Million |
Rp97.53 Billion ≈ $5.71 Million |
0.132x | -77.37% |
| 2014-12-31 | Rp191.08 Billion ≈ $11.20 Million |
Rp111.12 Billion ≈ $6.51 Million |
0.582x | +3.41% |
| 2013-12-31 | Rp133.01 Billion ≈ $7.79 Million |
Rp74.80 Billion ≈ $4.38 Million |
0.562x | -80.36% |
| 2012-12-31 | Rp19.22 Billion ≈ $1.13 Million |
Rp55.04 Billion ≈ $3.23 Million |
2.863x | +137.81% |
| 2011-12-31 | Rp-4.05 Billion ≈ $-237.07K |
Rp30.64 Billion ≈ $1.80 Million |
-7.573x | -- |
About Sarana Meditama Metropolitan
PT Sarana Meditama Metropolitan Tbk engages in the hospital management of EMC Hospital Pulomas in Pulomas, East Jakarta. The company operates specialty centers. It also is involved in trading of medical equipment; healthcare pharmacy; real estate; and agriculture. The company was founded in 1984 and is based in Jakarta, Indonesia. PT Sarana Meditama Metropolitan Tbk is a subsidiary of PT Elang Ma… Read more